Group One Trading’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $99.9K | Buy |
+14,350
| New | +$67.9K | ﹤0.01% | 4726 |
|
|
2025
Q4 | – | Hold |
0
| – | – | – | 9856 |
|
|
2025
Q3 | – | Sell |
-26,301
| Closed | -$25.2K | – | 9954 |
|
|
2025
Q2 | $15.8K | Sell |
26,301
-2,340
| -8% | -$1.2K | ﹤0.01% | 6426 |
|
|
2025
Q1 | $7.73K | Sell |
28,641
-73,446
| -72% | -$24.3K | ﹤0.01% | 6418 |
|
|
2024
Q4 | $53.1K | Buy |
102,087
+3,142
| +3% | +$7.66K | ﹤0.01% | 5010 |
|
|
2024
Q3 | $321K | Sell |
98,945
-49,982
| -34% | -$162K | 0.01% | 3208 |
|
|
2024
Q2 | $447K | Sell |
148,927
-35,411
| -19% | -$128K | 0.01% | 2670 |
|
|
2024
Q1 | $857K | Buy |
184,338
+25,911
| +16% | +$125K | 0.03% | 2226 |
|
|
2023
Q4 | $656K | Sell |
158,427
-2,076
| -1% | -$6.15K | 0.02% | 2843 |
|
|
2023
Q3 | $482K | Buy |
160,503
+23,948
| +18% | +$71.1K | 0.02% | 2949 |
|
|
2023
Q2 | $336K | Buy |
136,555
+92,861
| +213% | +$257K | 0.01% | 3424 |
|
|
2023
Q1 | $98.7K | Sell |
43,694
-99,841
| -70% | -$344K | ﹤0.01% | 4312 |
|
|
2022
Q4 | $501K | Buy |
+143,535
| New | +$1.26M | 0.02% | 3039 |
|
|
2022
Q3 | – | Sell |
-3,354
| Closed | -$92.9K | – | 8901 |
|
|
2022
Q2 | $64K | Buy |
+3,354
| New | +$73.2K | ﹤0.01% | 5360 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9293 |
|
|
2021
Q4 | – | Sell |
-2,035
| Closed | -$45.3K | – | 9406 |
|
|
2021
Q3 | $53K | Sell |
2,035
-5,185
| -72% | -$139K | ﹤0.01% | 6501 |
|
|
2021
Q2 | $231K | Buy |
7,220
+1,000
| +16% | +$34.7K | ﹤0.01% | 5083 |
|
|
2021
Q1 | $219K | Buy |
+6,220
| New | +$218K | ﹤0.01% | 4939 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7464 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7056 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6647 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6112 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6012 |
|
Other funds holding RLMD
SCM
SSC
VA
O
VCM
RCM